Cardiomyocyte-specific overexpression of Nitric Oxide Synthase 3 confers protection against apoptotic cardiomyocyte cell death
Glenn Marsboom(Johnson & Johnson (United States)), Stefan Janssens(Maastricht University), Hilde Gillijns(Ghent University), Marijke Pellens(Ghent University), Peter Jans, Man Jiang
European Heart Journal
August 1, 2006
Cited by 0
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
|Nature Medicine|2022|889
Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer
|The FASEB Journal|2012|606